122 related articles for article (PubMed ID: 24411340)
21. Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study.
Bristow AR; Agrawal A; Evans AJ; Burrell HC; Cornford EJ; James JJ; Hamilton L; Robertson JF; Chan SY; Lawton PA; Cheung KL
Breast; 2008 Feb; 17(1):98-103. PubMed ID: 17890090
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
23. Skeletal scintigraphy in breast cancer management.
Bares R
Q J Nucl Med; 1998 Mar; 42(1):43-8. PubMed ID: 9646644
[TBL] [Abstract][Full Text] [Related]
24. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
25. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
26. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
27. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Kut V; Spies W; Spies S; Gooding W; Argiris A
Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
[TBL] [Abstract][Full Text] [Related]
28. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
29. Performance of CT scan of abdomen and pelvis in detecting asymptomatic synchronous metastasis in breast cancer.
James J; Teo M; Ramachandran V; Law M; Stoney D; Cheng M
Int J Surg; 2017 Oct; 46():164-169. PubMed ID: 28890415
[TBL] [Abstract][Full Text] [Related]
30. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
Buscombe JR; Holloway B; Roche N; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
[TBL] [Abstract][Full Text] [Related]
31. Workup and staging of locally advanced breast cancer.
Whitman GJ; Strom EA
Semin Radiat Oncol; 2009 Oct; 19(4):211-21. PubMed ID: 19732685
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
33. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
[TBL] [Abstract][Full Text] [Related]
34. Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.
Segaert I; Mottaghy F; Ceyssens S; De Wever W; Stroobants S; Van Ongeval C; Van Limbergen E; Wildiers H; Paridaens R; Vergote I; Christiaens MR; Neven P
Breast J; 2010; 16(6):617-24. PubMed ID: 21070439
[TBL] [Abstract][Full Text] [Related]
35. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
36. Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
Henry NL; Braun TM; Breslin TM; Gorski DH; Silver SM; Griggs JJ
Cancer; 2017 Aug; 123(15):2975-2983. PubMed ID: 28301680
[TBL] [Abstract][Full Text] [Related]
37. The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
Garami Z; Hascsi Z; Varga J; Dinya T; Tanyi M; Garai I; Damjanovich L; Galuska L
Eur J Surg Oncol; 2012 Jan; 38(1):31-7. PubMed ID: 21937190
[TBL] [Abstract][Full Text] [Related]
38. Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario.
Kamel D; Youssef V; Hopman WM; Mates M
Curr Oncol; 2021 Jun; 28(3):2190-2198. PubMed ID: 34204717
[TBL] [Abstract][Full Text] [Related]
39. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
[TBL] [Abstract][Full Text] [Related]
40. Staging studies have limited utility for newly diagnosed stage I-II breast cancer.
Linkugel A; Margenthaler J; Dull B; Cyr A
J Surg Res; 2015 Jun; 196(1):33-8. PubMed ID: 25824669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
